Table 1.
Clinical Characteristics
| Measure | Cohort 1 (26 Men and 47 Women), Mean (Range) | Cohort 2 (97 Men and 233 Women), Mean (Range) |
|---|---|---|
| Age, y | 38 (22 to 62) | 39 (18 to 72) |
| BMI, kg/m2 | 29 (20 to 53) | 24.0 (17.8 to 29.9) |
| Body fat,% | 37 (16 to 74) | 29 (8 to 51) |
| Waist‐to‐hip ratio | 0.94 (0.71 to 1.21) | 0.89 (0.71 to 1.08) |
| apoB, g/L | 1.1 (0.5 to 2.1) | 0.9 (0.3 to 2.0) |
| apoA1 g/L | 1.4 (0.6 to 2.9) | 1.4 (0.8 to 2.9) |
| P‐triglycerides, mmol/L | 2.2 (0.4 to 20.0) | 1.4 (0.3 to 20.0) |
| P‐total cholesterol, mmol/L | 5.7 (2.6 to 9.8) | 4.8 (2.6 to 12.8) |
| P‐HDL cholesterol, mmol/L | 1.3 (0.5 to 2.9) | 1.5 (0.6 to 2.9) |
| HOMA‐IR index | 2.7 (0.7 to 25.6) | 1.4 (0.2 to 20.3) |
| Lipolysis, isoproterenol/basal | — | 9.9 (1.6 to 36.1) |
| Adipocyte triglyceride age, y | 1.9 (0.1 to 4.0) | 1.41 (0.02 to 3.84) |
| Adipocyte triglyceride uptake, kg/y | 24 (5 to 129) | — |
BMI indicates body mass index; Apo, apolipoprotein; P, fasting plasma; HDL, high‐density lipoprotein; HOMA‐IR, homeostatic model assessment–insulin resistance.